52
Halia Therapeutics, Inc. raises $337K under Reg D
Company raise · Raising · Offering $20M · Sold $337K · LEHI, UT · filed 2025-07-16
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Preston B. Campbell | Director |
| Mary B. Beckerle | Director |
| David Checketts | Director |
| Gary B. Sabin | Director |
| Jeffrey Burton | Executive Officer |
| David Bearss | Director |
| John S.K. Kauwe | Director |
Signed by Jeffrey Burton, Chief Financial Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.